Reta glucagon-like peptide-1 (GLP-1) receptor agonists represent a groundbreaking strategy to diabetes management. These innovative medications operate by mimicking the inherent actions of GLP-1, a hormone released by https://45listing.com/story22917360/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes